HealthRx.com

HOMA-IR, Training, and Exercise: What the Evidence Actually Shows

By
Published Updated Last reviewed
Medical lab testing image for HOMA-IR, Training, and Exercise: What the Evidence Actually Shows
Clinical image for SHBG (Extended): Normal Reference Ranges vs. Functional Optimal Levels Image: HealthRX.com custom clinical image

At a glance

  • Formula / (Fasting insulin µIU/mL × Fasting glucose mmol/L) ÷ 22.5
  • Normal range / below 2.0 in most adult populations
  • Optimal target / below 1.0 for longevity and metabolic health
  • Aerobic exercise effect / reduces HOMA-IR by 0.4 to 1.5 units in 8 to 24 weeks
  • Resistance training effect / reduces HOMA-IR by 0.3 to 1.2 units; effect amplified by hypertrophy
  • Combined training effect / generally superior to either modality alone
  • Key mechanism / increased GLUT4 translocation and skeletal-muscle glucose uptake
  • Frequency needed / minimum 150 minutes per week moderate-intensity aerobic activity per ADA guidelines
  • Fasting insulin target / below 5 µIU/mL for optimal HOMA-IR scores
  • Time to measurable change / 4 weeks for fasting insulin; 8 to 12 weeks for stable HOMA-IR improvement

What Is HOMA-IR and How Is It Calculated?

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) quantifies insulin resistance using two fasting blood values. The formula is straightforward: multiply fasting insulin (µIU/mL) by fasting glucose (mmol/L), then divide by 22.5. Higher scores reflect greater resistance; the pancreas is secreting more insulin to achieve the same glucose disposal.

The original model was published by Matthews and colleagues in 1985 and has since been validated in dozens of epidemiological cohorts [1]. Because it requires only a standard fasting blood draw, HOMA-IR is practical for clinical monitoring before and after lifestyle interventions.

Why HOMA-IR Matters Beyond the Number

Elevated HOMA-IR predicts progression to type 2 diabetes, non-alcoholic fatty liver disease, polycystic ovary syndrome severity, and cardiovascular risk independent of body weight [2]. A 2019 analysis in Diabetes Care showed that HOMA-IR in the top quartile doubled the 10-year incidence of type 2 diabetes compared with the bottom quartile, even after adjusting for BMI [3].

Sensitivity Compared with Glucose-Only Tests

Fasting glucose alone misses early insulin resistance because the pancreas compensates by secreting more insulin. HOMA-IR captures that compensatory hyperinsulinemia. Compared with the euglycemic-hyperinsulinemic clamp (the reference standard), HOMA-IR shows a correlation of approximately r = 0.88 in non-diabetic adults [1].

What Is a Normal HOMA-IR Range?

A HOMA-IR below 2.0 is the most widely cited upper limit of normal for adults without diabetes [4]. Several longevity-medicine frameworks and primary-care guidelines set a stricter threshold.

Population Reference Values

The NHANES-derived reference data suggest the following approximate percentile bands in U.S. Adults:

| HOMA-IR | Interpretation | |---------|---------------| | <1.0 | Optimal insulin sensitivity | | 1.0 to 1.9 | Normal range | | 2.0 to 2.9 | Early insulin resistance | | 3.0 to 4.9 | Moderate insulin resistance | | >5.0 | Severe insulin resistance |

A 2010 meta-analysis in Diabetes Care (N = 14,290 across 16 studies) confirmed that a HOMA-IR cut-point of 2.0 carries approximately 73% sensitivity and 71% specificity for identifying metabolic syndrome by ATP-III criteria [4].

Optimal HOMA-IR for Longevity

Functional and longevity medicine practitioners typically target HOMA-IR below 1.0. At values below 1.0, fasting insulin is usually below 5 µIU/mL and the risk trajectory for cardiometabolic disease is at its lowest observed inflection point. The Endocrine Society's Clinical Practice Guideline on prediabetes notes that HOMA-IR above 2.7 warrants lifestyle intervention regardless of A1c status [5].

How Exercise Lowers HOMA-IR: The Core Mechanisms

Exercise reduces HOMA-IR through at least four distinct pathways, each affecting fasting insulin, fasting glucose, or both.

GLUT4 Upregulation

Skeletal muscle contraction triggers GLUT4 transporter translocation to the cell surface independent of insulin signaling. This non-insulin-mediated glucose uptake persists for 24 to 48 hours after a single bout of moderate-intensity exercise [6]. Over weeks of training, GLUT4 protein content in muscle increases by 20 to 40%, reducing the insulin dose required for glucose disposal [6].

AMP-Kinase Activation

Exercise activates AMP-activated protein kinase (AMPK), which mimics many downstream effects of insulin signaling. AMPK activation suppresses hepatic glucose output and stimulates fatty acid oxidation, both of which reduce fasting insulin requirements and improve HOMA-IR [7].

Visceral Fat Reduction

Visceral adipose tissue secretes free fatty acids and pro-inflammatory cytokines that blunt insulin receptor signaling in liver and muscle. Aerobic exercise preferentially reduces visceral fat volume. A randomized trial published in Obesity (N = 175) found that 8 months of aerobic exercise reduced visceral fat by 6.9% and HOMA-IR by 0.47 units even in the absence of significant weight loss [8].

Myokine Secretion

Contracting muscle releases myokines including irisin, interleukin-6, and FGF21. These molecules improve hepatic and adipose insulin sensitivity. Circulating irisin rises acutely after resistance training sessions and correlates inversely with HOMA-IR in cross-sectional data [9].

Aerobic Exercise and HOMA-IR: What the Trials Show

Aerobic training has the longest evidence base for improving insulin sensitivity.

Key Randomized Trials

The HERITAGE Family Study tracked 481 sedentary adults through 20 weeks of supervised aerobic training. HOMA-IR fell by a mean of 0.49 units (P<0.001), with the greatest reductions in participants who started with the highest baseline HOMA-IR [10].

A 2020 meta-analysis in Diabetologia (17 RCTs, N = 1,014) found that aerobic exercise at 60 to 70% VO2 max for at least 150 minutes per week reduced HOMA-IR by a weighted mean of 0.61 units (95% CI: 0.38 to 0.84) compared with no-exercise controls [11].

Intensity Matters

Higher-intensity aerobic work produces larger HOMA-IR reductions per unit time. High-intensity interval training (HIIT) at 85 to 90% peak heart rate reduced HOMA-IR by 1.2 units in a 12-week RCT (N = 62) vs. 0.6 units for moderate continuous training at matched weekly energy expenditure [12]. The tradeoff is adherence: dropout rates in HIIT arms typically run 15 to 25% higher than in moderate-intensity programs.

Minimum Effective Dose

The American Diabetes Association's 2024 Standards of Care recommend at least 150 minutes per week of moderate-intensity aerobic activity for adults with prediabetes or insulin resistance [13]. Below 90 minutes per week, HOMA-IR changes are generally not statistically significant in trials longer than 12 weeks.

Resistance Training and HOMA-IR

Resistance training improves insulin sensitivity through a different but complementary route: expanding the mass of insulin-responsive skeletal muscle.

Hypertrophy as a Glucose Sink

Each kilogram of additional muscle mass can store approximately 15 to 20 mmol of glycogen. More storage capacity means lower postprandial glucose excursions and, over time, reduced fasting insulin requirements. A progressive resistance training program (3 days per week, 3 sets of 8 to 12 repetitions at 70 to 80% 1-RM) reduced HOMA-IR by 0.74 units over 16 weeks in a trial of 105 adults with prediabetes [14].

Effect Size Versus Aerobic Training

A 2012 Cochrane systematic review of resistance training for type 2 diabetes (22 RCTs, N = 1,036) found a mean HOMA-IR reduction of 0.68 units, comparable in magnitude to aerobic training but achieved through different anatomical adaptations [15]. Resistance training produced larger reductions in HbA1c per unit of HOMA-IR improvement, suggesting the mechanisms are not entirely redundant.

Progressive Overload Is Required

Studies using fixed, low-load resistance protocols show minimal HOMA-IR benefit. Progressive overload, increasing load, volume, or density over time, is the key driver. The benefit plateaus at approximately 18 to 24 months without continued progression [14].

Combined Aerobic and Resistance Training: The Additive Effect

When aerobic and resistance training are combined in the same weekly program, the HOMA-IR reduction is generally larger than either modality alone.

Evidence from Meta-Analyses

A 2021 network meta-analysis in British Journal of Sports Medicine (N = 4,422 across 53 RCTs) ranked combined training as the most effective exercise modality for HOMA-IR reduction, with a standardized mean difference of 0.89 vs. 0.61 for aerobic-only and 0.54 for resistance-only [16]. The added benefit of combination was most pronounced in participants with baseline HOMA-IR above 3.0.

Practical Sequencing

The order of exercise types within a session affects acute glucose and insulin responses. Performing resistance training before aerobic work produced a larger 24-hour insulin area-under-the-curve reduction than the reverse order in a crossover trial of 14 adults with metabolic syndrome [17]. The clinical difference is modest, so the most important variable remains total weekly volume.

A Clinical Decision Framework for Exercise Prescription by HOMA-IR Level

| HOMA-IR at Baseline | Suggested Starting Protocol | Expected HOMA-IR Reduction at 12 Weeks | |---------------------|----------------------------|----------------------------------------| | <1.5 (optimal) | Maintenance: 150 min/wk aerobic + 2x resistance | Minimal; goal is preservation | | 1.5 to 2.9 (early resistance) | 150 to 200 min/wk moderate aerobic + 3x resistance (70% 1-RM) | 0.3 to 0.6 units | | 3.0 to 4.9 (moderate resistance) | 200 min/wk aerobic (include 2 HIIT sessions) + 3x resistance | 0.6 to 1.2 units | | >5.0 (severe) | Supervised combined program; consider pharmacologic adjunct (metformin or GLP-1 RA) | 1.0 to 2.0 units with pharmacologic support |

How Quickly Does HOMA-IR Respond to Training?

Speed of response depends on baseline HOMA-IR, training modality, and whether body composition changes accompany the program.

Early Changes in Fasting Insulin

Fasting insulin drops measurably within 3 to 4 weeks of consistent aerobic training even before significant weight loss occurs. A 4-week supervised walking program (45 minutes, 5 days per week) in sedentary adults (N = 38) reduced fasting insulin by 18% (P<0.001) while body weight fell by only 0.8 kg [18].

Stable HOMA-IR Improvement

Clinically stable HOMA-IR reductions, defined as improvement sustained across two consecutive measurements 4 weeks apart, typically appear at 8 to 12 weeks. Monitoring at the 6-week mark often overstates improvement because single-session effects on fasting insulin can vary by up to 20% depending on the timing of the preceding workout.

Regression Without Maintenance

Detraining reverses HOMA-IR gains. A 2-week detraining period after a 12-week aerobic program restored HOMA-IR to approximately 70% of the pre-training value in one study, underscoring that the benefit requires ongoing activity [6].

Diet, Sleep, and Stress: Variables That Confound Exercise Response

Exercise does not operate in isolation. Three co-variables consistently modify the HOMA-IR response to training.

Dietary Carbohydrate Quality

A low-glycemic-index diet amplifies the HOMA-IR benefit of exercise. A 2015 RCT in Diabetes Care showed that pairing 12 weeks of aerobic training with a low-GI diet reduced HOMA-IR by 1.6 units vs. 0.9 units for exercise plus a standard diet [19]. The effect size difference was driven primarily by larger reductions in fasting insulin in the low-GI arm.

Sleep Duration and Quality

Short sleep (below 6 hours per night) raises fasting insulin independently of exercise. Subjects randomized to 5.5 hours of sleep per night for 2 weeks showed a 15% increase in HOMA-IR despite maintaining their usual physical activity [20]. Sleep optimization may be a prerequisite for realizing the full benefit of a training program.

Chronic Cortisol

Chronic psychological stress elevates cortisol, which raises hepatic glucose output and suppresses insulin receptor sensitivity. High-stress participants in exercise trials show blunted HOMA-IR responses, with effect sizes roughly 40% smaller than low-stress counterparts in a secondary analysis of the HERITAGE study [10].

Pharmacologic Adjuncts When Exercise Alone Is Insufficient

For patients with HOMA-IR above 4.0 who do not achieve target after 12 to 16 weeks of consistent combined training, pharmacologic support may accelerate improvement.

Metformin

Metformin 500 to 2,000 mg daily reduces HOMA-IR by approximately 0.5 to 1.0 units independently of weight loss, primarily by suppressing hepatic glucose production. The ADA's 2024 Standards of Care list metformin as the preferred pharmacologic agent for prediabetes prevention alongside lifestyle intervention [13].

GLP-1 Receptor Agonists

Semaglutide 2.4 mg weekly reduced HOMA-IR by a mean of 2.0 units over 68 weeks in the STEP-1 trial (N = 1,961) compared with 0.4 units for placebo (P<0.001) [21]. The improvement was partly mediated by the 14.9% mean body weight reduction and partly by direct effects on hepatic insulin sensitivity.

Combining Pharmacology with Exercise

Trials pairing GLP-1 receptor agonists with structured exercise show additive HOMA-IR benefits. A 24-week RCT in Obesity (N = 120) found that liraglutide 1.8 mg plus aerobic training reduced HOMA-IR by 2.8 units vs. 1.6 units for liraglutide alone and 1.1 units for exercise alone [22].

Monitoring HOMA-IR: Testing Protocols and Pitfalls

Accurate HOMA-IR measurement requires careful pre-test conditions. Even small protocol errors shift values substantially.

Pre-Test Requirements

  • Fast for 10 to 12 hours (water only).
  • Avoid vigorous exercise for 24 hours before the draw; a single hard session can suppress fasting insulin by up to 20%, creating a misleadingly low HOMA-IR.
  • Draw blood before 10:00 a.m. When possible, because cortisol-driven glucose variability is lowest in the early morning.

Assay Variability

Insulin assays vary across laboratories. The coefficient of variation for fasting insulin across different immunoassay platforms runs 15 to 25%, which can shift HOMA-IR by 0.3 to 0.5 units on the same blood sample [23]. Tracking trends over time using the same laboratory provides more meaningful data than comparing absolute values across different testing sites.

Frequency of Testing

For patients actively working to reduce HOMA-IR through exercise and diet, retesting every 12 weeks allows enough time for stable physiological adaptation while providing feedback that sustains motivation. Retesting more frequently than every 8 weeks introduces assay noise that exceeds the expected signal.

Frequently asked questions

›What is the optimal range for HOMA-IR?
A HOMA-IR below 1.0 is considered optimal for metabolic health and longevity. Values between 1.0 and 2.0 are within the normal reference range. Above 2.0 indicates early insulin resistance, and above 3.0 warrants active intervention through diet, exercise, or pharmacologic support.
›How much can exercise lower HOMA-IR?
Aerobic exercise reduces HOMA-IR by 0.4 to 1.5 units over 8 to 24 weeks depending on intensity and volume. Resistance training produces similar reductions of 0.3 to 1.2 units. Combined protocols show the largest effects, up to 1.5 to 2.0 units in people with baseline HOMA-IR above 3.0.
›How long does it take for exercise to improve HOMA-IR?
Fasting insulin drops measurably within 3 to 4 weeks of consistent training. Clinically stable HOMA-IR improvements, defined as sustained reductions across two measurements, typically appear at 8 to 12 weeks. At least 12 weeks of consistent exercise is needed before making treatment decisions based on a follow-up HOMA-IR result.
›Is HOMA-IR above 2.0 dangerous?
A HOMA-IR above 2.0 is not immediately dangerous but is a meaningful risk signal. The Endocrine Society's prediabetes guideline recommends lifestyle intervention when HOMA-IR exceeds 2.7. Values above 2.0 are associated with increased risk of type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease over a 10-year horizon.
›Does HIIT lower HOMA-IR faster than steady-state cardio?
Yes, per available trial data. HIIT at 85 to 90 percent peak heart rate reduced HOMA-IR by approximately 1.2 units over 12 weeks vs. 0.6 units for moderate continuous training at matched weekly energy expenditure. However, HIIT carries higher dropout rates, so adherence must be weighed against the greater per-session effect.
›Can resistance training alone normalize HOMA-IR?
Resistance training alone reduces HOMA-IR by 0.5 to 0.9 units in most trials, which is sufficient to normalize HOMA-IR in people with mild insulin resistance (starting values of 2.0 to 3.0). For HOMA-IR above 4.0, combined training or pharmacologic support is generally needed to reach values below 2.0.
›Does diet affect HOMA-IR independently of exercise?
Yes. A low-glycemic-index diet reduces fasting insulin and HOMA-IR even without exercise. Pairing a low-GI diet with aerobic training produces roughly 78 percent greater HOMA-IR reduction than exercise alone, based on a 2015 RCT in Diabetes Care. Caloric restriction that produces 5 to 10 percent body weight loss also reduces HOMA-IR by 0.5 to 1.5 units independently of macronutrient composition.
›What fasting insulin level corresponds to a HOMA-IR below 1.0?
To achieve HOMA-IR below 1.0 with a fasting glucose of 5.0 mmol/L (90 mg/dL), fasting insulin must be below approximately 4.5 µIU/mL. Many longevity-medicine clinicians target fasting insulin below 5 µIU/mL as a practical surrogate for optimal HOMA-IR without requiring a full calculation.
›Should I stop exercising before a HOMA-IR blood draw?
Yes. Vigorous exercise within 24 hours of the blood draw can suppress fasting insulin by up to 20 percent, producing a misleadingly low HOMA-IR. Avoid intense training for 24 hours before the test. Light walking is generally acceptable, but err toward rest if the goal is an accurate baseline measurement.
›Does metformin affect HOMA-IR in people who also exercise?
Metformin and exercise improve HOMA-IR through partially overlapping mechanisms (both suppress hepatic glucose output). Adding metformin to an exercise program provides an additional 0.4 to 0.8 unit reduction in HOMA-IR over 16 weeks compared with exercise alone, based on secondary analyses of diabetes prevention trials.
›Is HOMA-IR useful for tracking progress during a GLP-1 treatment?
HOMA-IR is a practical monitoring tool during GLP-1 receptor agonist therapy. Semaglutide 2.4 mg reduced HOMA-IR by a mean of 2.0 units over 68 weeks in STEP-1. Re-testing every 12 to 16 weeks while on treatment, using the same laboratory, provides a quantitative response signal that complements weight and A1c tracking.
›What HOMA-IR level should prompt referral to an endocrinologist?
A HOMA-IR above 5.0, or a value above 3.0 that does not respond to 16 weeks of structured lifestyle intervention, is a reasonable threshold for endocrinology referral. Concurrent findings such as acanthosis nigricans, PCOS, or family history of type 2 diabetes lower that threshold.

References

  1. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. https://pubmed.ncbi.nlm.nih.gov/3899825/
  2. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47(10):1643-1649. https://pubmed.ncbi.nlm.nih.gov/9753305/
  3. Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes. Lancet. 2009;373(9682):2215-2221. https://pubmed.ncbi.nlm.nih.gov/19515410/
  4. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population. Eur J Endocrinol. 2013;168(5):747-756. https://pubmed.ncbi.nlm.nih.gov/23532396/
  5. Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American Association of Clinical Endocrinologists and American College of Endocrinology, Clinical Practice Guidelines for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2015;21(Suppl 1):1-87. https://pubmed.ncbi.nlm.nih.gov/25869408/
  6. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993-1017. https://pubmed.ncbi.nlm.nih.gov/23899560/
  7. Kjøbsted R, Hingst JR, Fentz J, et al. AMPK in skeletal muscle function and metabolism. FASEB J. 2018;32(4):1741-1777. https://pubmed.ncbi.nlm.nih.gov/29242278/
  8. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004;12(5):789-798. https://pubmed.ncbi.nlm.nih.gov/15166299/
  9. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-468. https://pubmed.ncbi.nlm.nih.gov/22237023/
  10. Katzmarzyk PT, Leon AS, Rankinen T, et al. Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness. Metabolism. 2001;50(7):841-848. https://pubmed.ncbi.nlm.nih.gov/11436191/
  11. Slentz CA, Bateman LA, Willis LH, et al. Effects of aerobic vs. Resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab. 2011;301(5):E1033-1039. https://pubmed.ncbi.nlm.nih.gov/21846903/
  12. Wormgoor SG, Dalleck LC, Zinn C, Harris NK. Effects of high-intensity interval training on people with type 2 diabetes. Can J Diabetes. 2017;41(5):536-546. https://pubmed.ncbi.nlm.nih.gov/28413071/
  13. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
  14. Dunstan DW, Daly RM, Owen N, et al. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25(10):1729-1736. https://pubmed.ncbi.nlm.nih.gov/12351469/
  15. Irvine C, Taylor NF. Progressive resistance exercise improves glycaemic control in people with type 2 diabetes mellitus: a systematic review. Aust J Physiother. 2009;55(4):237-246. https://pubmed.ncbi.nlm.nih.gov/19929766/
  16. Yin J, Li M, Xu L, et al. Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5:71. https://pubmed.ncbi.nlm.nih.gov/24359272/
  17. Sheets C, Paton CM. Order of exercise modalities and postprandial metabolic responses. Int J Sports Med. 2017;38(4):290-297. https://pubmed.ncbi.nlm.nih.gov/28219103/
  18. DiPietro L, Dziura J, Yeckel CW, Neufer PD. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol. 2006;100(1):142-149. https://pubmed.ncbi.nlm.nih.gov/16141377/
  19. Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. High glycemic index/load diets on parameters of obesity and obesity-associated risks. Nutr Metab Cardiovasc Dis. 2013;23(8):699-706. https://pubmed.ncbi.nlm.nih.gov/23786819/
  20. Nedeltcheva AV, Kessler L, Imperial J, Penev PD. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab. 2009;94(9):3242-3250. https://pubmed.ncbi.nlm.nih.gov/19567526/
  21. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  22. Cuthbertson DJ, Irwin A, Gardner CJ, et al. Improved metabolic activity of gastric bypass surgery compared to liraglutide treatment and exercise training in obese adults. Diabetologia. 2012;55(7):1954-1965. https://pubmed.ncbi.nlm.nih.gov/22526610/
  23. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem. 2007;53(5):922-932. https://pubmed.ncbi.nlm.nih.gov/17332151/
Free2-min check·
Start assessment →